Na Zhang1, Xinfeng Liu1,2, Qi Yang3, Shlee S. Song4, Zhenliang Xiong1,5, Lei Zhang1, Hairong Zheng1, Xin Liu1, and Zhaoyang Fan3,6
1Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China, 2Department of Radiology, Guizhou Provicial People's Hospital, Guiyang, China, 3Biomedical Imaging Research Institute, Cedars Sinai Medical Center, Los Angeles, CA, United States, 4Department of Neurology, Cedars Sinai Medical Center, Los Angeles, CA, United States, 5Guizhou University School Of Medicine, Guiyang, China, 6Department of Medicine, University of California, Los Angeles, CA, United States
Synopsis
Conventional
intracranial
MR vessel wall imaging (VWI) techniques based on 3D turbo spin-echo (TSE), with
a thin, oblique slab to specifically target a limited imaging volume, have been
shown to be reliable in quantifying vessel morphology of intracranial
atherosclerotic disease (ICAD). Recently, 3D whole-brain VWI was proposed and
optimized offering large spatial coverage, improved cerebrospinal fluid
suppression, and enhanced T1 weighting and exhibits excellent reproducibility
in quantification of vessel dimensions in healthy volunteers. This study is to
further evaluate the clinical reliability of 3D whole-brain VWI in patients
with ICAD via a comparison
with 3D targeted VWI and 2D TSE.
Introduction
High resolution MR vessel wall imaging (VWI) has demonstrated the
potential to reveal the lesions of intracranial atherosclerotic disease (ICAD) and characterize their morphological
and signal features which are intimately associated with recent clinical events
1,2. Conventional intracranial VWI techniques based on 3D turbo
spin-echo (TSE), with a thin, oblique slab to specifically target a limited
imaging volume, have been shown to be reliable in quantifying vessel wall
morphology of ICAD3,4. However, the 3D targeted VWI approach only
covers major intracranial arteries, which may miss the culprit lesions at some
arterial branches. Recently, 3D whole-brain VWI was proposed and optimized offering
large spatial coverage, improved cerebrospinal fluid (CSF)
suppression, and enhanced T1 weighting5,6. This technique exhibits
excellent reproducibility in quantification of intracranial vessel dimensions
in healthy volunteers7. The aim of this study is to further evaluate
the clinical reliability of 3D whole-brain VWI in patients with ICAD via a comparison
with 3D targeted VWI and 2D TSE.Materials and Methods
Fifteen patients (13 males, age 40-69 years) with recent (127.87±134.02 days)
ischemic cerebrovascular events and clinically confirmed etiology as ICAD were
recruited to undergo two repeated VWI sessions with an interval of at least one
week on a 3T MR system (Siemens Trio). In each session, the following imaging protocol
was performed: pre-contrast T1-weighted VWI (i.e. whole-brain VWI, targeted
VWI, and 2D TSE), contrast-enhanced MRA, and post-contrast T1-weighted VWI
(i.e. only one 3D VWI followed by 2D TSE). Relevant imaging parameters of the
two 3D sequences were matched: isotropic 0.53mm spatial resolution without
interpolation, GRAPPA factor = 2, scan time = 8min 10sec for whole-brain VWI
and 8min 3sec for targeted VWI. For each patient, 3 contiguous short-axis
slices of the most severe plaque reconstructed from 3D images were used for the
single-slice 2D TSE scan (spatial resolution 0.53×0.53×2mm3). Lumen
and vessel wall area, volume, plaque burden, percent stenosis, remodeling ratio,
lesion-to-wall
contrast ratio (CR), and enhancement ratio (ER) were measured at all plaques. Using
VesselMass software, two readers (both with 8-year experience in vascular MR) independently
performed above geometric and signal measurements on the images from the first
imaging session. After two weeks, one reader performed a second-round
measurement on the same data, and the other performed measurement on the images
from the second imaging session. Following analyses were then performed: 1) the
intra- and inter-observer agreement and scan-rescan reproducibility of each
sequence; 2) the agreement in dimension quantification between each of the 3D
sequences and 2D TSE; 3) the superiority in lesion contrast among the three
sequences.Results
Twenty-eight plaques were detected in the 15 patients. All 3D scans provided
good delineation of plaques (arrows in Fig.1
and 2). However, some plaques were missed by targeted VWI due to the
limited coverage (arrowheads in Fig. 1).
Outer boundary of some plaques was difficult to discern on targeted VWI because
of insufficient CSF suppression (Fig. 2).
All morphologic measurements and intra-class correlation coefficients (ICC) with
95% confidence interval (CI) of each sequence summarized in Table 1 exhibited good to excellent
reproducibility (all ICC≥0.72). The paired
morphologic measurements of 15 plaques for 3D and 2D techniques and their
agreement are summarized in Table 2.
All ICCs were greater or equal to 0.79, indicating excellent agreement between either
of the 3D VWI technique and 2D TSE. In addition, the lesion-to-wall CR of
whole-brain VWI (1.97±0.31) was significantly
higher than that of targeted VWI (1.46±0.19,
p<0.001) and 2D TSE (1.67±0.18,
p=0.02). The plaque ER of whole-brain VWI (1.94±0.61) was slightly
higher than that of 2D TSE (1.86±0.33, p=0.374) but significantly higher than
that of targeted VWI (1.58±0.46, p<0.001) (Fig. 3).Discussion and Conclusion
In general, this study demonstrated excellent agreement between 3D and
2D techniques, and good to excellent reproducibility of inter-scan, intra-, and
inter-observer. However, whole-brain VWI generally exhibited higher ICCs than
targeted VWI and 2D TSE. This was more likely attributed to the
improved CSF suppression and T1 weighting of whole-brain VWI. The
remarkable attenuation of surrounding CSF signals improved the conspicuity of
outer boundary of vessel wall, hence improved the accuracy of morphological
measurements. Additionally, improved T1 contrast resulted in significantly
higher lesion-to-wall CR and plaque ER in whole-brain VWI than in targeted VWI
and 2D TSE. This might contribute to a better capacity to evaluate plaque
features. With such high reproducibility for plaque geometric and burden
measurement, the whole-brain VWI can potentially be used for quantifying longitudinal
morphologic changes in ICAD, and hence monitoring therapy
and disease progression. In conclusion, the proposed whole-brain VWI is a
reproducible and more sensitive MR method for ICAD assessment.Acknowledgements
This work was supported in part by National Natural Science Foundation
of China (81830056) and National Key R&D Program of China (2016YFC0100100).References
1. Go AS, Mozaffarian D,
Roger VL, et al. Heart disease and stroke statistics--2014 update: a report
from the American Heart Association. Circulation 2014; 129(3):e28-e292.
2. Wong LK. Global burden
of intracranial atherosclerosis. Int J Stroke 2006; 1(3):158-159.
3. Qiao Y, Steinman DA,
Qin Q, et al. Intracranial arterial wall imaging using three-dimensional high
isotropic resolution black blood MRI at 3.0 Tesla. J Magn Reson Imaging
2011;34(1):22-30.
4. Qiao
Y, Anwar Z, Intrapiromkul J, et al. Patterns and Implications of Intracranial
Arterial Remodeling in Stroke Patients. Stroke. 2016; 47(2):434-40.
5. Fan Z, Yang Q, Deng Z,
et al. Whole-brain intracranial vessel wall imaging at 3 Tesla using
cerebrospinal fluid-attenuated T1-weighted 3D turbo spin echo. Magn Reson Med
2017;77(3):1142-1150.
6. Yang Q, Deng Z, Bi X,
et al. Whole-brain vessel wall MRI: A parameter tune-up solution to improve
the scan efficiency of three-dimensional variable flip-angle turbo spin-echo.
J Magn Reson Imaging. 2017; 46(3):751-757.
7. Zhang N, Zhang F,
Deng Z, et al. 3D whole-brain vessel wall cardiovascular
magnetic resonance imaging: a study on the reliability in the quantification of
intracranial vessel dimensions. J Cardiovasc Magn Reson. 2018;
20(1):39.